iiCON is a world leading centre for infection innovation and R&D – working with industry, academics, and clinicians to save and improve lives around the world by supporting innovation …

Operating across eleven commercially sustainable specialist research platforms, iiCON’s collaborative effort is directly reducing the global burden of infectious disease with a …

iiCON provides access to eleven commercially sustainable specialist research platforms, co-developed and operated by our industrial, academic, and clinical partners.

Founding Director of iiCON and Professor of Tropical Medicine at LSTM, Professor Hemingway was appointed the Director of LSTM in 2001 and stepped down in 2019 having overseen a …

iiCON Annual Report 2024 Click below to read and download our latest annual report, exploring achievements and activity from October 2023 to October 2024. Click here to download report

After successful sandpit events in Liverpool and London earlier this year, iiCON (Infection Innovation Consortium) is excited to announce 11 new projects. These projects are focused on …

iiCON’s Surfaces Platform supported the Ministry of Defence to validate a cheap, effective disinfectant, Virusend, that inactivates coronavirus in 60 seconds. The environmentally friendly …

Infection Innovation Consortium (iiCON), Liverpool Life Sciences Accelerator, 1 Daulby Street, Liverpool L7 8XZ. [email protected]

iiCON, in collaboration with LJMU and AFRIMS in Thailand, is developing a microwave sensor to assess the concentration of Etofenprox and Permethrin insecticides on military uniforms. The …

Led by LSTM, iiCON brings together public and private partners in a £170 million programme born out of the Liverpool City Region. The consortium builds on the North West’s UK-leading …